AAAAAA

   
Results: 1-15 |
Results: 15

Authors: Hombach, A Muche, JM Gerken, M Gellrich, S Heuser, C Pohl, C Sterry, W Abken, H
Citation: A. Hombach et al., T cells engrafted with a recombinant anti-CD30 receptor target autologous CD30(+) cutaneous lymphoma cells, GENE THER, 8(11), 2001, pp. 891-895

Authors: Hombach, A Heuser, C Marquardt, T Wieczarkowiecz, A Groneck, V Pohl, C Abken, H
Citation: A. Hombach et al., CD4(+) T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion, J IMMUNOL, 167(2), 2001, pp. 1090-1096

Authors: Hombach, A Wieczarkowiecz, A Marquardt, T Heuser, C Usai, L Pohl, C Seliger, B Abken, H
Citation: A. Hombach et al., Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can ge integrated into one combined CD28/CD3 zeta signaling receptor molecule, J IMMUNOL, 167(11), 2001, pp. 6123-6131

Authors: Hombach, A Sent, D Schneider, C Heuser, C Koch, D Pohl, C Seliger, B Abken, H
Citation: A. Hombach et al., T-cell activation by recombinant receptors: CD28 costimulation is requiredfor interleukin 2 secretion and receptor-mediated T-cell proliferation butdoes not affect receptor-mediated target cell lysis, CANCER RES, 61(5), 2001, pp. 1976-1982

Authors: Hombach, A Heuser, C Gerken, M Fischer, B Lewalter, K Diehl, V Pohl, C Abken, H
Citation: A. Hombach et al., T cell activation by recombinant Fc epsilon RI gamma-chain immune receptors: an extracellular spacer domain impairs antigen-dependent T cell activation but not antigen recognition, GENE THER, 7(12), 2000, pp. 1067-1075

Authors: Pohl, C Hombach, A Kruis, W
Citation: C. Pohl et al., Chronic inflammatory bowel disease and cancer, HEP-GASTRO, 47(31), 2000, pp. 57-70

Authors: Allgayer, H Tillmann, T Hombach, A Kruis, W Pohl, C
Citation: H. Allgayer et al., Aminosalicylates and aspirin for colonic cancer: From anti-inflammatory toantineoplastic drugs?, Z GASTROENT, 38(12), 2000, pp. 963-970

Authors: Hombach, A Schneider, C Sent, D Koch, D Willemsen, RA Diehl, V Kruis, W Bolhuis, RL Pohl, C Abken, H
Citation: A. Hombach et al., An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood T cells to specific lysis of carcinoembryonic antigen-positive tumor cells, INT J CANC, 88(1), 2000, pp. 115-120

Authors: Hombach, A Heuser, C Sircar, R Tillmann, T Diehl, V Pohl, C Abken, H
Citation: A. Hombach et al., Characterization of a chimeric T-cell receptor with specificity for the Hodgkin's lymphoma-associated CD30 antigen, J IMMUNOTH, 22(6), 1999, pp. 473-480

Authors: Hombach, A Cassing, W Teis, S Mosel, U
Citation: A. Hombach et al., Analysis of flow effects in relativistic heavy-ion collisions within the CBUU approach, EUR PHY J A, 5(2), 1999, pp. 157-172

Authors: Hombach, A Cassing, W Mosel, U
Citation: A. Hombach et al., Isospin equilibration in relativistic heavy-ion collisions, EUR PHY J A, 5(1), 1999, pp. 77-84

Authors: Hombach, A Koch, D Sircar, R Heuser, C Diehl, V Kruis, W Pohl, C Abken, H
Citation: A. Hombach et al., A chimeric receptor that selectively targets membrane-bound carcinoembryonic antigen (mCEA) in the presence of soluble CEA, GENE THER, 6(2), 1999, pp. 300-304

Authors: Hombach, A Pohl, C Heuser, C Sircar, R Koch, D Diehl, V Abken, H
Citation: A. Hombach et al., Generation of the single chain antibody fragment conserves the idiotypic profile of the anti-CD30 monoclonal antibody HRS3. (vol 48, pg 497, 1998), SC J IMMUN, 50(2), 1999, pp. 232-232

Authors: Hombach, A Pohl, C Reinhold, U Abken, H
Citation: A. Hombach et al., Grafting T cells with tumor specificity: The chimeric receptor strategy for use in immunotherapy of malignant diseases, HYBRIDOMA, 18(1), 1999, pp. 57-61

Authors: Reinhold, U Liu, LD Ludtke-Handjery, HC Heuser, C Hombach, A Wang, XH Tilgen, W Ferrone, S Abken, H
Citation: U. Reinhold et al., Specific lysis of melanoma cells by receptor grafted T cells is enhanced by anti-idiotypic monoclonal antibodies directed to the scFv domain of the receptor, J INVES DER, 112(5), 1999, pp. 744-750
Risultati: 1-15 |